Marc J. Prindle, Ph.D.

Affiliations: 
2007 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Cell Biology
Google:
"Marc Prindle"

Parents

Sign in to add mentor
Gregory R. Dressler grad student 2007 University of Michigan
 (Characterization of the role of PTIP in the DNA damage response.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Schmitt MW, Fox EJ, Prindle MJ, et al. (2015) Sequencing small genomic targets with high efficiency and extreme accuracy. Nature Methods. 12: 423-5
Schmitt MW, Fox EJ, Prindle MJ, et al. (2015) Abstract LB-283: Human cancers harbor extensive subclonal mutations Cancer Research. 75
Kennedy SR, Schmitt MW, Fox EJ, et al. (2014) Detecting ultralow-frequency mutations by Duplex Sequencing. Nature Protocols. 9: 2586-606
Prindle MJ, Loeb LA, Estey EH, et al. (2014) Targeted Ultra-Deep High Accuracy Sequencing of Pre-Treatment AML Reveals a Diversity of Mutational Phenotypes and Evidence of Preexisting Relapse-Associated Subclones Blood. 124: 2372-2372
Weedon MN, Ellard S, Prindle MJ, et al. (2013) An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy Nature Genetics. 45: 947-950
Fox EJ, Prindle MJ, Loeb LA. (2013) Do mutator mutations fuel tumorigenesis? Cancer Metastasis Reviews. 32: 353-61
Prindle MJ, Schmitt MW, Parmeggiani F, et al. (2013) A substitution in the fingers domain of dna polymerase reduces fidelity by altering nucleotide discrimination in the catalytic site Journal of Biological Chemistry. 288: 5572-5580
Prindle MJ, Loeb LA. (2012) DNA polymerase delta in dna replication and genome maintenance Environmental and Molecular Mutagenesis. 53: 666-682
Schmitt MW, Prindle MJ, Loeb LA. (2012) Implications of genetic heterogeneity in cancer Annals of the New York Academy of Sciences. 1267: 110-116
Prindle MJ, Fox EJ, Loeb LA. (2010) The mutator phenotype in cancer: molecular mechanisms and targeting strategies. Current Drug Targets. 11: 1296-303
See more...